Poolbeg Pharma PLC (POLBF)
USD 0.15
(27.97%)
USD 0.15
(27.97%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -4.66 Million GBP | 6.05% |
| 2022 | -4.96 Million GBP | -113.98% |
| 2021 | -3.09 Million GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -2.24 Million GBP | -217001.45% |
| 2023 FY | - GBP | -1.13% |
| 2023 Q4 | -1295.00 GBP | 0.0% |
| 2023 Q3 | -1295.00 GBP | 99.94% |
| 2023 Q1 | -1035.00 GBP | 99.97% |
| 2022 Q2 | -1.87 Million GBP | -215196.15% |
| 2022 FY | - GBP | -113.98% |
| 2022 Q4 | -3.36 Million GBP | -208903.42% |
| 2022 Q3 | -1610.50 GBP | 99.91% |
| 2022 Q1 | -869.50 GBP | 0.0% |
| 2021 FY | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.06 Million USD | -52.138% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -31.379% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -103.984% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 73.172% |
| GB Sciences, Inc. | -1.41 Million USD | -228.196% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 1330.058% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -38006.141% |
| Skye Bioscience, Inc. | -13.54 Million USD | 65.603% |
| Zenith Capital Corp. | -8.6 Million USD | 45.852% |
| Agentix Corp. | -1.37 Million USD | -239.711% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -19.97% |
| Biomind Labs Inc. | -1.03 Million USD | -350.438% |
| ContraFect Corporation | -64.99 Million USD | 92.831% |
| CSL Limited | 4.78 Billion USD | 100.097% |
| CytoDyn Inc. | -18.02 Million USD | 74.153% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 69403.986% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -636.868% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 91.579% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -1168.991% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -203.376% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -397.359% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 104.955% |
| SQZ Biotechnologies Company | -64.14 Million USD | 92.735% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -213.296% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 93.44% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -76.218% |
| Mesoblast Limited | -62.38 Million USD | 92.531% |
| Marizyme, Inc. | -34.28 Million USD | 86.407% |
| Genus plc | 73.7 Million USD | 106.323% |
| Pharming Group N.V. | 9.87 Million USD | 147.18% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 46.876% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -232.428% |
| IMV Inc. | -35.52 Million USD | 86.882% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -100.532% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -799.534% |
| ONE Bio Corp. | 13.61 Million USD | 134.232% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 90.337% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 230.459% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -61.116% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 34.928% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -18540.0% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 70.636% |
| Alpha Cognition Inc. | -9.7 Million USD | 51.986% |
| Enzolytics Inc. | -2.12 Million USD | -119.601% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -216.02 Million USD | 97.843% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 482.909% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 152.633% |
| Genscript Biotech Corporation | -248.71 Million USD | 98.126% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 21.402% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -1848.568% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -90.479% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -2547.361% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -142.593% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 29.517% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -2.956% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -24.385% |
| Helix BioMedix, Inc. | -1.04 Million USD | -345.374% |
| EV Biologics, Inc. | -1.26 Million USD | -267.76% |
| Q BioMed Inc. | -617.62 Thousand USD | -654.499% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -166.286% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 88.243% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.55 Million USD | 38.308% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -86.254% |
| HST Global, Inc. | -5303.00 USD | -87774.788% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -126.544% |
| Halberd Corporation | -74.27 Thousand USD | -6173.644% |
| Resverlogix Corp. | -11.74 Million USD | 60.313% |
| Cell Source, Inc. | -4.27 Million USD | -9.069% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -210.893% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -6.11 Million USD | 23.765% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -26649.326% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -1.03 Million USD | -350.33% |
| Kadimastem Ltd | -2.62 Million USD | -77.566% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -1127.543% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -2473.335% |
| LadRx Corporation | 412.28 Thousand USD | 1230.292% |
| Regen BioPharma, Inc. | 1.46 Million USD | 417.881% |
| Affymax, Inc. | -14.29 Million USD | 67.401% |
| Itoco Inc. | -1.86 Million USD | -149.332% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -317.563% |
| Mobile Lads Corp. | -2.24 Million USD | -107.928% |
| International Stem Cell Corporation | 202 Thousand USD | 2406.931% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -3.82 Million USD | -21.985% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -5796.57% |
| Qrons Inc. | -40.08 Thousand USD | -11526.456% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -859.483% |
| SYBLEU INC | -141.57 Thousand USD | -3191.635% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 983.525% |
| Rebus Holdings, Inc. | -951 Thousand USD | -390.011% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -338.791% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -8752.584% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -89.282% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 87.008% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -10255.556% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -70.197% |
| Neutra Corp. | -181.24 Thousand USD | -2471.077% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 76.884% |
| PureTech Health plc | -11.62 Million USD | 59.921% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 76.882% |
| IXICO plc | -707 Thousand USD | -559.123% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 39.362% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 90.361% |
| CSL Limited | 4.73 Billion USD | 100.098% |
| Cellectis S.A. | -92.63 Million USD | 94.97% |